abs30.txt	background	&	aims		estimates	of	disease	burden	can	inform	national	healthpriorities	for	research	clinical	care	and	policy	we	aimed	to	estimate	healthcare	use	spending	among	gastrointestinal	(gi)	(including	luminal	liver	andpancreatic)	diseases	in	the	united	states	methods	estimated	health	based	on	most	currentlyavailable	administrative	claims	from	commercial	medicare	supplemental	plans	data	gi	quality	improvement	consortium	registry	databases	results	2015	annual	expenditures	diseasestotaled	$135	9	billion	hepatitis	($23	3	billion)	esophageal	disorders	($18	1billion)	biliary	tract	($10	abdominal	pain	2	inflammatory	bowel	($7	were	expensive	yearly	there	more	than	54	4	million	ambulatory	visits	with	a	primary	diagnosis	fora	0	hospital	admissions	540	500	all-cause	30-dayreadmissions	266	600	new	cases	cancers	diagnosed	144	300cancer	deaths	each	year	97	700	non-malignant	gidiseases	an	11	colonoscopies	6	1	upper	endoscopies	313	000	flexible	sigmoidoscopies	178	400	endoscopic	ultrasoundexaminations	169	retrograde	cholangiopancreatographyprocedures	performed	annually	average-risk	persons	ages	50-75	yearswho	underwent	colonoscopy	34	6%	had	or	adenomatous	polyps	7%	ormore	advanced	5	serrated	removed	conclusions	contribute	substantially	theunited	total	are	dollarsannually-greater	other	common	likely	tocontinue	increasing
